Nutrition Support Use and Clinical Outcomes in Patients with Multiple Myeloma Undergoing Autologous Stem Cell Transplant

Overview

Journal Support Care Cancer

Specialties Critical Care
Oncology

Date 2022 Sep 11

PMID 36089605

Authors

Julia Kuypers

Natalie Simmance

Hang Quach

Katherine Hastie

Nicole Kiss

Affiliations

Soon will be listed here.

Abstract

Purpose: Malnutrition is associated with worse outcomes post-haematopoietic stem cell transplantation, with nutrition support recommended for people who are malnourished or have prolonged inadequate energy intake. We investigated associations between nutritional status, nutrition support type and clinical outcomes in adults with multiple myeloma post stem cell transplantation.

Methods: Medical records (2015-2020) were reviewed to retrieve demographics, anthropometry, dietary data, nutrition support type (enteral/oral versus parenteral), and clinical outcomes (engraftment time, infection, length of stay, weight changes). Relationships were examined using linear regression modelling and Fisher's exact test.

Results: One hundred thirteen participants were included (61% male; median age 62 years). Fifteen participants (13%) received parenteral and 98 (87%) received enteral/oral nutrition support. Parenteral nutrition was associated with shorter platelet engraftment time by 2.7 days (p = 0.036) and a longer hospital stay by 6.1 days (p < 0.001). Nutrition support was not associated with neutrophil engraftment time (p = 0.365). Inadequate energy intake for ≥ 7 days was not associated with any clinical outcomes (p > 0.05).

Conclusions: Participants who received parenteral nutrition reached platelet engraftment sooner but were in hospital longer. Inadequate energy intake for ≥ 7 days did not impact clinical outcomes. Multi-site prospective studies are warranted to confirm results.

Citing Articles

Nutritional and Body Composition Changes in Paediatric β-Thalassemia Patients Undergoing Hematopoietic Stem Cell Transplantation: A Retrospective Study Using Bioelectrical Impedance Analysis.

Zhang L, Wang L, Long J, Yin Y, Patil S J Multidiscip Healthc. 2024; 17:2203-2214.

PMID: 38751668 PMC: 11094366. DOI: 10.2147/JMDH.S463796.

Polymorphism (rs1143634) and IL-1β Plasma Concentration as Predictors of Nutritional Disorders and Prognostic Factors in Multiple Myeloma Patients.

Mazurek M, Szudy-Szczyrek A, Homa-Mlak I, Hus M, Malecka-Massalska T, Mlak R Cancers (Basel). 2024; 16(7).

PMID: 38610941 PMC: 11011170. DOI: 10.3390/cancers16071263.

References

Garzon Herazo J, Munoz Velandia O, Solano J, Molina Pimienta L, Figueroa Lemus W . The nutrition risk index is associated with bacteremia within 30 days after autologous stem cell transplantation in patients with multiple myeloma. Transpl Infect Dis. 2020; 22(4):e13302. DOI: 10.1111/tid.13302. View

Chou W, Hung Y, Kao C, Su P, Hsieh C, Chen J . Impact of palliative care consultative service on disease awareness for patients with terminal cancer. Support Care Cancer. 2013; 21(7):1973-81. DOI: 10.1007/s00520-013-1733-7. View

Ha L, Hauge T, Spenning A, Iversen P . Individual, nutritional support prevents undernutrition, increases muscle strength and improves QoL among elderly at nutritional risk hospitalized for acute stroke: a randomized, controlled trial. Clin Nutr. 2010; 29(5):567-73. DOI: 10.1016/j.clnu.2010.01.011. View

Arends J, Baracos V, Bertz H, Bozzetti F, Calder P, Deutz N . ESPEN expert group recommendations for action against cancer-related malnutrition. Clin Nutr. 2017; 36(5):1187-1196. DOI: 10.1016/j.clnu.2017.06.017. View

Urbain P, Birlinger J, Ihorst G, Biesalski H, Finke J, Bertz H . Body mass index and bioelectrical impedance phase angle as potentially modifiable nutritional markers are independent risk factors for outcome in allogeneic hematopoietic cell transplantation. Ann Hematol. 2012; 92(1):111-9. DOI: 10.1007/s00277-012-1573-4. View

Moiseev I, Tsvetkova T, Aljurf M, Alnounou R, Bogardt J, Chalandon Y . Clinical and morphological practices in the diagnosis of transplant-associated microangiopathy: a study on behalf of Transplant Complications Working Party of the EBMT. Bone Marrow Transplant. 2018; 54(7):1022-1028. DOI: 10.1038/s41409-018-0374-3. View

Azam F, Latif M, Farooq A, Tirmazy S, Alshahrani S, Bashir S . Performance Status Assessment by Using ECOG (Eastern Cooperative Oncology Group) Score for Cancer Patients by Oncology Healthcare Professionals. Case Rep Oncol. 2019; 12(3):728-736. PMC: 6792426. DOI: 10.1159/000503095. View

Isenring E, Cross G, Daniels L, Kellett E, Koczwara B . Validity of the malnutrition screening tool as an effective predictor of nutritional risk in oncology outpatients receiving chemotherapy. Support Care Cancer. 2006; 14(11):1152-6. DOI: 10.1007/s00520-006-0070-5. View

Reber E, Friedli N, Vasiloglou M, Schuetz P, Stanga Z . Management of Refeeding Syndrome in Medical Inpatients. J Clin Med. 2019; 8(12). PMC: 6947262. DOI: 10.3390/jcm8122202. View

10.

Bauer J, Capra S, Ferguson M . Use of the scored Patient-Generated Subjective Global Assessment (PG-SGA) as a nutrition assessment tool in patients with cancer. Eur J Clin Nutr. 2002; 56(8):779-85. DOI: 10.1038/sj.ejcn.1601412. View

11.

Thoresen L, Fjeldstad I, Krogstad K, Kaasa S, Falkmer U . Nutritional status of patients with advanced cancer: the value of using the subjective global assessment of nutritional status as a screening tool. Palliat Med. 2002; 16(1):33-42. DOI: 10.1191/0269216302pm486oa. View

12.

Jaeschke R, Guyatt G, Dellinger P, Schunemann H, Levy M, Kunz R . Use of GRADE grid to reach decisions on clinical practice guidelines when consensus is elusive. BMJ. 2008; 337:a744. DOI: 10.1136/bmj.a744. View

13.

Duggan P, Booth K, Chaudhry A, Stewart D, Ruether J, Gluck S . Unrelated donor BMT recipients given pretransplant low-dose antithymocyte globulin have outcomes equivalent to matched sibling BMT: a matched pair analysis. Bone Marrow Transplant. 2002; 30(10):681-6. DOI: 10.1038/sj.bmt.1703674. View

14.

Lipkin A, Lenssen P, Dickson B . Nutrition issues in hematopoietic stem cell transplantation: state of the art. Nutr Clin Pract. 2005; 20(4):423-39. DOI: 10.1177/0115426505020004423. View

15.

Azarnoush S, Bruno B, Beghin L, Guimber D, Nelken B, Yakoub-Agha I . Enteral nutrition: a first option for nutritional support of children following allo-SCT?. Bone Marrow Transplant. 2012; 47(9):1191-5. DOI: 10.1038/bmt.2011.248. View

16.

Girma T, Kaestel P, Molgaard C, Ritz C, Andersen G, Michaelsen K . Utility of bio-electrical impedance vector analysis for monitoring treatment of severe acute malnutrition in children. Clin Nutr. 2020; 40(2):624-631. DOI: 10.1016/j.clnu.2020.06.012. View

17.

Sheean P, Kilkus J, Liu D, Maciejewski J, Braunschweig C . Incident hyperglycemia, parenteral nutrition administration and adverse outcomes in patients with myeloma admitted for initial auto-SCT. Bone Marrow Transplant. 2013; 48(8):1117-22. PMC: 3661701. DOI: 10.1038/bmt.2013.11. View

18.

Aksoy S, Dizdar O, Harputluoglu H, Altundag K . Demographic, clinical, and pathological characteristics of Turkish triple-negative breast cancer patients: single center experience. Ann Oncol. 2007; 18(11):1904-6. DOI: 10.1093/annonc/mdm487. View

19.

Schulenburg A, Turetschek K, Wrba F, Vogelsang H, Greinix H, Keil F . Early and late gastrointestinal complications after myeloablative and nonmyeloablative allogeneic stem cell transplantation. Ann Hematol. 2003; 83(2):101-6. DOI: 10.1007/s00277-003-0756-4. View

20.

Gordillo C, Parmar S, Blanco M, Delille E, Assal A, Mapara M . Gastrointestinal toxicity of high-dose melphalan in autologous hematopoietic stem cell transplantation: identification of risk factors and a benchmark for experimental therapies. Ann Hematol. 2021; 100(7):1863-1870. PMC: 11531332. DOI: 10.1007/s00277-020-04378-8. View